Miraculins Signs on Investment Firm Bloom Burton for Financial Advice | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Miraculins today said that it has signed on investment firm Bloom Burton as an advisor to the company.

Bloom Burton, based in Toronto, will provide strategic and financial services, including an overview and analysis of potential opportunities, financial modeling, analysis of Miraculins' business plan, an overview and assessment of financing options, and strategic partnership opportunities, Miraculins said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.